A detailed history of State Of Wisconsin Investment Board transactions in Adma Biologics, Inc. stock. As of the latest transaction made, State Of Wisconsin Investment Board holds 207,321 shares of ADMA stock, worth $4.52 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
207,321
Previous 155,892 32.99%
Holding current value
$4.52 Million
Previous $1.74 Million 137.89%
% of portfolio
0.01%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$11.21 - $20.03 $576,519 - $1.03 Million
51,429 Added 32.99%
207,321 $4.14 Million
Q2 2024

Aug 14, 2024

SELL
$5.98 - $11.18 $1.98 Million - $3.71 Million
-331,884 Reduced 68.04%
155,892 $1.74 Million
Q1 2024

May 14, 2024

BUY
$4.4 - $6.74 $1.44 Million - $2.21 Million
327,711 Added 204.74%
487,776 $3.22 Million
Q4 2023

Feb 12, 2024

SELL
$3.08 - $4.52 $12,705 - $18,645
-4,125 Reduced 2.51%
160,065 $723,000
Q3 2023

Nov 14, 2023

SELL
$3.47 - $4.61 $11,718 - $15,567
-3,377 Reduced 2.02%
164,190 $587,000
Q2 2023

Aug 14, 2023

SELL
$3.12 - $4.22 $27,824 - $37,633
-8,918 Reduced 5.05%
167,567 $618,000
Q1 2023

May 15, 2023

SELL
$3.01 - $3.87 $54,327 - $69,849
-18,049 Reduced 9.28%
176,485 $584,000
Q4 2022

Feb 14, 2023

BUY
$2.47 - $3.88 $480,498 - $754,791
194,534 New
194,534 $754,000
Q3 2020

Nov 16, 2020

SELL
$2.04 - $3.74 $221,340 - $405,790
-108,500 Closed
0 $0
Q1 2020

May 06, 2020

BUY
$1.5 - $4.59 $101,250 - $309,825
67,500 Added 164.63%
108,500 $312,000
Q3 2019

Nov 12, 2019

BUY
$3.19 - $5.39 $45,936 - $77,616
14,400 Added 54.14%
41,000 $182,000
Q2 2019

Aug 14, 2019

BUY
$3.52 - $5.24 $2,112 - $3,144
600 Added 2.31%
26,600 $103,000
Q1 2019

May 13, 2019

BUY
$2.61 - $4.35 $15,660 - $26,099
6,000 Added 30.0%
26,000 $99,000
Q4 2018

Feb 11, 2019

BUY
$2.17 - $6.12 $43,400 - $122,400
20,000 New
20,000 $48,000

Others Institutions Holding ADMA

About ADMA BIOLOGICS, INC.


  • Ticker ADMA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 196,356,992
  • Market Cap $4.28B
  • Description
  • ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...
More about ADMA
Track This Portfolio

Track State Of Wisconsin Investment Board Portfolio

Follow State Of Wisconsin Investment Board and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of Wisconsin Investment Board, based on Form 13F filings with the SEC.

News

Stay updated on State Of Wisconsin Investment Board with notifications on news.